Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3604)
All Articles published online
|
Oct 15, 2012 (publication date) through Jun 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4(10): 207-215 [PMID: 23444312 DOI: 10.4251/wjgo.v4.i10.207] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v4/i10/207.htm |
| Number | Citing Articles |
| 1 |
Khalid A. Jazieh, Michael B. Foote, Luis A. Diaz. The Clinical Utility of Biomarkers in the Management of Pancreatic Adenocarcinoma. Seminars in Radiation Oncology 2014; 24(2): 67 doi: 10.1016/j.semradonc.2013.11.007
|
| 2 |
Stephan Schorn, Ihsan Ekin Demir, Carmen Mota Reyes, Cemil Saricaoglu, Nicole Samm, Rebekka Schirren, Elke Tieftrunk, Daniel Hartmann, Helmut Friess, Güralp Onur Ceyhan. The impact of neoadjuvant therapy on the histopathological features of pancreatic ductal adenocarcinoma – A systematic review and meta-analysis. Cancer Treatment Reviews 2017; 55: 96 doi: 10.1016/j.ctrv.2017.03.003
|
| 3 |
Klaus Felix, Ulf Hinz, Sophie Dobiasch, Thilo Hackert, Frank Bergmann, Magnus Neumüller, Simon Gronowitz, Mattias Bergqvist, Oliver Strobel. Preoperative Serum Thymidine Kinase Activity as Novel Monitoring, Prognostic, and Predictive Biomarker in Pancreatic Cancer. Pancreas 2018; 47(1): 72 doi: 10.1097/MPA.0000000000000966
|
| 4 |
Ebru Esen, Mehmet Aslan, Sevket Baris Morkavuk, Cem Azili, Siyar Ersoz, Ibrahim Burak Bahcecioglu, Ali Ekrem Unal. Can combined use of tumor markers in pancreatic cancer be a solution to short- and long-term consequences?: A retrospective study. Medicine 2023; 102(11): e33325 doi: 10.1097/MD.0000000000033325
|
| 5 |
Weiwei Sheng, Ming Dong, Guosen Wang, Xiaoyang Shi, Wei Gao, Kewei Wang, He Song, Gang Shi, Xiaodong Tan. The diversity between curatively resected pancreatic head and body-tail cancers based on the 8th edition of AJCC staging system: a multicenter cohort study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6178-z
|
| 6 |
Nicolás Macías, José M. Sayagués, Carmen Esteban, Manuel Iglesias, Luís M. González, Jose Quiñones-Sampedro, María L. Gutiérrez, Luís A. Corchete, Maria M. Abad, Oscar Bengoechea, Luís Muñoz-Bellvis. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy. Journal of Clinical Gastroenterology 2018; 52(2): e11 doi: 10.1097/MCG.0000000000000793
|
| 7 |
Zibo Meng, Mingsi Cao, Yushun Zhang, Zhiqiang Liu, Shihong Wu, Heshui Wu. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0975-3
|
| 8 |
Artem Boyev, Laura R. Prakash, Yi-Ju Chiang, Timothy E. Newhook, Morgan L. Bruno, Elsa M. Arvide, Whitney L. Dewhurst, Michael P. Kim, Naruhiko Ikoma, Jeffrey E. Lee, Rebecca A. Snyder, Ching-Wei D. Tzeng, Matthew H.G. Katz, Jessica E. Maxwell. Elevated CA 19-9 is associated with worse survival in patients with resected ampullary adenocarcinoma. Surgical Oncology 2023; 51: 101994 doi: 10.1016/j.suronc.2023.101994
|
| 9 |
Olca Basturk, Burcu Saka, Serdar Balci, Lauren M. Postlewait, Jessica Knight, Michael Goodman, David Kooby, Juan M. Sarmiento, Bassel El-Rayes, Hyejeong Choi, Pelin Bagci, Alyssa Krasinskas, Brian Quigley, Michelle D. Reid, Gizem Akkas, Shishir K. Maithel, Volkan Adsay. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging. Annals of Surgical Oncology 2015; 22(S3): 1187 doi: 10.1245/s10434-015-4861-0
|
| 10 |
Ioannis Mintziras, Sabine Wächter, Jerena Manoharan, Veit Kanngiesser, Elisabeth Maurer, Detlef Klaus Bartsch. Postoperative morbidity following pancreatic cancer surgery is significantly associated with worse overall patient survival; systematic review and meta-analysis. Surgical Oncology 2021; 38: 101573 doi: 10.1016/j.suronc.2021.101573
|
| 11 |
Bong-Il Song. Nomogram using F-18 fluorodeoxyglucose positron emission tomography/computed tomography for preoperative prediction of lymph node metastasis in gastric cancer. World Journal of Gastrointestinal Oncology 2020; 12(4): 447-456 doi: 10.4251/wjgo.v12.i4.447
|
| 12 |
Clémence Balaj, Ahmet Ayav, Alexandre Oliver, François Jausset, Caroline Sellal, Michel Claudon, Valérie Laurent. CT imaging of early local recurrence of pancreatic adenocarcinoma following pancreaticoduodenectomy. Abdominal Radiology 2016; 41(2): 273 doi: 10.1007/s00261-015-0564-z
|
| 13 |
Ahmet Bilici. Prognostic factors related with survival in patients with pancreatic adenocarcinoma. World Journal of Gastroenterology 2014; 20(31): 10802-10812 doi: 10.3748/wjg.v20.i31.10802
|
| 14 |
Nicky Zhun Hong Wong, Dominic Wei Ting Yap, Sherryl Lei Ng, Junie Yu Ning Ng, Juanita Jaslin James, Alfred Wei Chieh Kow. Oncological outcomes in minimally invasive vs. open distal pancreatectomy: a systematic review and network meta-analysis. Frontiers in Surgery 2024; 11 doi: 10.3389/fsurg.2024.1369169
|
| 15 |
Cynthia E. Weber, Eileen A. Bock, Michael G. Hurtuk, Gerard J. Abood, Jack Pickleman, Margo Shoup, Gerard V. Aranha. Clinical and Pathologic Features Influencing Survival in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma. Journal of Gastrointestinal Surgery 2014; 18(2): 340 doi: 10.1007/s11605-013-2388-x
|
| 16 |
M. Sandini, K. J. Ruscic, C. R. Ferrone, M. Qadan, M. Eikermann, A. L. Warshaw, K. D. Lillemoe, Carlos Fernández-del Castillo. Major Complications Independently Increase Long-Term Mortality After Pancreatoduodenectomy for Cancer. Journal of Gastrointestinal Surgery 2019; 23(10): 1984 doi: 10.1007/s11605-018-3939-y
|
| 17 |
Takehito Yamamoto, Shintaro Yagi, Hiromitsu Kinoshita, Yusuke Sakamoto, Kazuyuki Okada, Kenji Uryuhara, Takeshi Morimoto, Satoshi Kaihara, Ryo Hosotani. Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis. World Journal of Gastroenterology 2015; 21(1): 262-268 doi: 10.3748/wjg.v21.i1.262
|
| 18 |
Martin Lovecek, Pavel Skalicky, Dusan Klos, Linda Bebarova, Cestmir Neoral, Jiri Ehrmann, Jana Zapletalova, Hana Svebisova, Radek Vrba, Martin Stasek, Tharani Yogeswara, Roman Havlik. Long-term survival after resections for pancreatic ductal adenocarcinoma. Single centre study. Biomedical Papers 2016; 160(2): 280 doi: 10.5507/bp.2016.011
|
| 19 |
Hironobu Takano, Toru Nakamura, Takahiro Tsuchikawa, Toshihiro Kushibiki, Kouji Hontani, Kazuho Inoko, Mizuna Takahashi, Shoki Sato, Hirotake Abe, Shintaro Takeuchi, Nagato Sato, Kei Hiraoka, Hiroshi Nishihara, Toshiaki Shichinohe, Satoshi Hirano. Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice. Oncotarget 2015; 6(38): 41063 doi: 10.18632/oncotarget.5729
|
| 20 |
Georgios Gemenetzis, Vincent P. Groot, Alex B. Blair, Daniel A. Laheru, Lei Zheng, Amol K. Narang, Elliot K. Fishman, Ralph H. Hruban, Jun Yu, Richard A. Burkhart, John L. Cameron, Matthew J. Weiss, Christopher L. Wolfgang, Jin He. Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection. Annals of Surgery 2019; 270(2): 340 doi: 10.1097/SLA.0000000000002753
|
| 21 |
Weikang Liu, Yongsu Ma, Bingjun Tang, Chang Qu, Yiran Chen, Yinmo Yang, Xiaodong Tian. Predictive Model of Early Death of Resectable Pancreatic Ductal Adenocarcinoma After Curative Resection: A SEER-Based Study. Cancer Control 2022; 29: 107327482210848 doi: 10.1177/10732748221084853
|
| 22 |
Aryavarta M. S. Kumar, Gavin A. Falk, Robert Pelley, R. Matthew Walsh, May Abdel-Wahab. Adjuvant chemoradiation may improve survival over adjuvant chemotherapy in resected pancreatic cancer patients who are high risk for locoregional recurrence. Journal of Radiation Oncology 2015; 4(3): 271 doi: 10.1007/s13566-015-0186-7
|
| 23 |
Guodong Shi, Jingjing Zhang, Zipeng Lu, Dongfang Liu, Yang Wu, Pengfei Wu, Jie Yin, Hao Yuan, Qicong Zhu, Lei Chen, Yue Fu, Yunpeng Peng, Yan Wang, Kuirong Jiang, Yi Miao. A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma. Oncotarget 2017; 8(67): 110849 doi: 10.18632/oncotarget.22861
|